Showing 931-940 of 8921 results for "".
Addressing Skin Changes During Menopause: An Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/addressing-skin-changes-during-menopause-an-update/20220/New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.A Case Presentation of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37154/Alina Bridges, DO, Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, presents a case study involving a patient who had been on multiple treatments to present prurituJournal Club: Efficacy of Systemics After Discontinuation
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-efficacy-of-systemics-after-discontinuation/32829/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by Naiem T. Issa, MD, PhD, to discuss an article Dr. Issa authored reviewing published literature on the efficacy of biologics as monotherapy for atopic dermatitis following discontinuation. Issa NT, Abdin R, et al.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.The Impact of Clascoterone Topical Cream, 1%
https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/Clascoterone topical cream, 1% (Winlevi, Sun Pharmaceuticals, Inc.) approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older.Taking Action: Quality of Care in AD
https://practicaldermatology.com/topics/atopic-dermatitis/taking-action-quality-of-care-in-ad/19881/Beyond identifying barriers to AD patient care, the Quality of Care in Atopic Dermatitis initiative presents potential solutions. Eric Simpson, MD, MCR outlines some key strategies for improving care and emphasizes that some simple steps can make a big difference.Content marketing in the age of COVID 19
https://practicaldermatology.com/topics/practice-management/content-marketing-in-the-age-of-covid-19/19836/COVID-19 has changed everything, probably including the way you promote your practice. Content marketing has become more challenging, and more important than ever. Check out this short video from Ekwa Marketing to learn what to do (and what not to do) for a successful content marketing strategy.Should I Recommend Products that Claim to Contain Probiotics?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/should-i-recommend-products-that-claim-to-contain-probiotics/19829/The language of the microbiome can be confusing. Dr. Friedman prefers to focus on symbiotics when making topical product recommendations.Chin Up
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/chin-up/19689/Placement of a small volume of filler in the chin can be the secret to creating an ideal aesthetic in the lower face, according to Sabrina Fabi, MD. She discusses the anatomy of the face and explains why this approach can be so successful.Cosmetic Bootcamp 2019: Presenter Recaps
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-bootcamp-2019-presenter-recaps/19631/In its 15th year, Cosmetic Bootcamp continues to bring together core aesthetic physicians to earn about new and emerging interventions. Mary Lupo, MD; Jeanine Downie, MD; Jose Raul Montes, MD; Diane Berson, MD; Ava Shamban, MD; and Deborah Sherman, MD recap their presentations.